NutriBand (NTRB) Receivables - Other (2024 - 2026)

NutriBand (NTRB) posted Receivables - Other of $100000.0 for Q2 2026, little changed sequentially from $100000.0 in Q1 2026.

NutriBand (NTRB) Receivables - Other (2024 - 2026) Analysis & Trends

NutriBand has reported Receivables - Other for 3 years, with the latest figure at $100000.0 in Q2 2026.

Quarterly Receivables - Other changed N/A year-over-year to $100000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $100000.0 (changed N/A YoY) and the FY2026 annual result came in at $100000.0, changed N/A from the prior year.
Receivables - Other held at $100000.0 in Q2 2026 per NTRB's latest filing, from $100000.0 in the prior quarter.
Over five years, Receivables - Other peaked at $100000.0 in Q1 2024 and troughed at $100000.0 in Q1 2024.
A 3-year average of $100000.0 and a median of $100000.0 in 2024 frame the typical range for Receivables - Other.
The widest YoY moves for Receivables - Other: up 0.0% in 2025, down 0.0% in 2025.
Over 3 years, Receivables - Other stood at $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
According to Business Quant data, Receivables - Other over the past three periods registered $100000.0, $100000.0, and $100000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	NutriBand	57.74 Mn	53.73 Mn	196,801.00

Download Data